Scientists have welcomed the 'truly wonderful development' of a new drug for a hard-to-treat and aggressive form of .Researchers led by a team at University of said their new treatment 'quadrupled' three-year survival rates and increased average survival by 1.6 months.Academics said that the new drug, which works by cutting off the tumour's food supply, is the first of its type for mesothelioma in 20 years.
Load More
Load More